Company Pay Ratios
Publicly traded companies are required to disclose the pay ratio between their chief executive officers and median employees. High CEO-to-worker pay ratios contribute to economic inequality and can undermine employee morale and productivity. The average S&P 500 company’s CEO-to-worker pay ratio was 272-to-1 in 2022.
Ticker | Company | Median Worker Pay Sort ascending | Pay Ratio |
---|---|---|---|
APO | Apollo Asset Management, Inc. | $253,242 | 48:1 |
MEIP | Mei Pharma, Inc. | $252,808 | 10:1 |
TXG | 10x Genomics, Inc. | $252,567 | 74:1 |
AGIO | Agios Pharmaceuticals, Inc. | $251,489 | 50:1 |
OHI | Omega Healthcare Investors Inc. | $251,150 | 44:1 |
NGM | Ngm Biopharmaceuticals Inc. | $251,078 | 24:1 |
SRPT | Sarepta Therapeutics, Inc. | $249,890 | 494:1 |
ENTA | Enanta Pharmaceuticals Inc. | $249,345 | 29:1 |
RDUS | Radius Health, Inc. | $248,946 | 14:1 |
XHR | Xenia Hotels & Resorts, Inc. | $248,639 | 29:1 |
ETSY | Etsy Inc. | $248,232 | 66:1 |
INCY | Incyte Corp. | $247,678 | 67:1 |
TBPH | Theravance Biopharma, Inc. | $247,108 | 25:1 |
VRTS | Virtus Investment Partners, Inc. | $246,948 | 26:1 |
WETF | Wisdomtree, Inc. | $246,806 | 22:1 |
XPER | Adeia Inc. | $246,490 | 48:1 |
EGRX | Eagle Pharmaceuticals, Inc. | $245,274 | 43:1 |
AVDL | Avadel Pharmaceuticals PLC | $244,878 | 3:1 |
GTHX | G1 Therapeutics, Inc. | $243,930 | 12:1 |
ICPT | Intercept Pharmaceuticals, Inc. | $243,657 | 18:1 |
Pagination
NOTE: For companies with more than one CEO during the year, the highest-paid CEO is included in the database. Pay ratio between CEO pay and median employee pay are displayed as disclosed by each company’s proxy statement. The CEO pay ratio may not equal the displayed CEO’s total compensation due to differing company methodologies in calculating pay ratios.
Terms and Data Sources | Contact the Press Office